Navegando por Assunto "Sangue"

Agora exibindo 1 - 2 de 2

Acesso aberto (Open Access)
Detection of HTLV-IIa in blood donors in an urban area of the Amazon Region of Brazil (Belém, PA)
(1998-04) ISHAK, Ricardo; ISHAK, Marluísa de Oliveira Guimarães; SANTOS, Domingos Ezenildo Matos dos; VALLINOTO, Antonio Carlos Rosário; SARAIVA, João Carlos Pina; CRESCENTE, Jose Angelo Barletta; HALL, William W.; AZEVEDO, Vânia Nakauth
The human lymphotropic viruses type I (HTLV-I) and type II (HTLV-II) are members of a group of mammalian retroviruses with similar biological properties, and blood transfusion is an important route of transmission. HTLV-I is endemic in a number of different geographical areas and is associated with several clinical disorders. HTLV-II is endemic in several Indian groups of the Americas and intravenous drug abusers in North and South America, Europe and Southeast Asia. During the year of 1995, all blood donors tested positive to HTLV-I/II in the State Blood Bank (HEMOPA), were directed to a physician and to the Virus Laboratory at the Universidade Federal do Pará for counselling and laboratory diagnosis confirmation. Thirty-five sera were tested by an enzyme immune assay, and a Western blot that discriminates HTLV-I and HTLV-II infection. Two HTLV-II positive samples were submitted to PCR analysis of pX and env genomic region, and confirmed to be of subtype IIa. This is the first detection in Belém of the presence of HTLV-IIa infection among blood donors. This result emphasizes that HTLV-II is also present in urban areas of the Amazon region of Brazil and highlights the need to include screening tests that are capable to detect antibodies for both types of HTLV.
Acesso aberto (Open Access)
Inibição e reversão da agregação plaquetária de eqüinos in vitro com o uso de ketoprofeno, fenilbutazona e flunixim meglumine
(2009-10) LEME, Fabiola de Oliveira Paes; WURZINGER, Laurenz; ALVES, Geraldo Eleno Silveira; BICALHO, Adriane Pimenta da Costa-Val; BARBOSA, Marcos Pinott; PAES, Paulo Ricardo de Oliveira; OLIVEIRA, Marcos Enê Chaves
Several diseases may lead to platelet pre-activation and hypercoagulability states in horses. The activity of many drugs against platelet aggregation may, not only contribute to the evaluation of a disease but also its response to the therapy. With the aim to study in vitro prevention and reversion of platelet aggregation, the non steroidal anti-inflammatory drug (NSAID): ketoprophen, phenylbutazone and flunixin-meglumin were evaluated. The comparison demonstrated that phenylbutazone and ketoprophen prevented platelet aggregation induced by ADP better than flunixin-meglumin, in a superior manner to the monoclonal antibody Reopro, and in a better way than the membrane receptor blockers Ro-438857 and RGDS. The reversion of platelet aggregation demonstrated that even phenylbutazone or ketoprophen have a dose-dependent effect.